NJDOH Proposes to Readopt, with Amendments, Repeals, and New Rules, N.J.A.C. 8:51, Childhood Blood Lead At or Above the Blood Lead Reference Value, and N.J.A.C. 8:51A, Screening of Children for Blood Lead At or Above the Blood Lead Reference Value
The Child and Adolescent Health Program of the New Jersey Department of Health is proposing to readopt, with amendments, repeals, and new rules, N.J.A.C. 8:51, Childhood Blood Lead At or Above the Blood Lead Reference Value, which establishes public health standards to help reduce, and eventually eliminate, elevated blood lead levels in children through lead screening, lead poisoning control, and abatement of identified lead hazards. This includes the determination of the level of lead in a child’s bloodstream that necessitates responsive action. In addition, the Department is proposing to readopt with amendments N.J.A.C. 8:51A, Screening of Children for Blood Lead At or Above the Blood Lead Reference Value, which implements the lead screening requirements, including the age of the child when initial screening is to be conducted, the time intervals between screening, the indicators that warrant follow-up testing, and the methods to be used to conduct lead screening.
Learn More >